Scalable, high throughput microfluidic platforms for tissue specific biomaterials development and tissue genesis

用于组织特异性生物材料开发和组织发生的可扩展、高通量微流体平台

• 批准号: DP1095429
• 负责人: Prof Justin Cooper-White
• 金额: $ 27.89万
• 依托单位: The University of Queensland
• 依托单位国家: 澳大利亚
• 项目类别: Discovery Projects
• 财政年份: 2010
• 资助国家: 澳大利亚
• 起止时间: 2010-01-01 至 2012-12-31
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/DP1095429
• 关键词: Scalable; throughput; microfluidic; platforms; tissue

The co-development of novel biomaterial platforms and new generation production methods for tissue analogues will provide the necessary stimulus for improved and more relevant methods of enhanced repair or regeneration of diseased or damaged tissues. These outcomes will result in faster time-to-market new generation therapeutic products for Australia and the world. These advances will have a significant impact on our healthcare costs and the quality of life for all Australians.

新型生物材料平台和新一代组织类似物生产方法的共同开发将为改善和增强患病或受损组织的修复或再生的更相关方法提供必要的刺激。这些成果将为澳大利亚和世界带来更快的新一代治疗产品上市时间。这些进步将对我们的医疗保健成本和所有澳大利亚人的生活质量产生重大影响。